Skip Navigation
Skip to contents

CPP : Cardiovascular Prevention and Pharmacotherapy

Sumissioin : submit your manuscript
SEARCH
Search

Search

Page Path
HOME > Search
3 "Junghyun Noh"
Filter
Filter
Article category
Keywords
Publication year
Authors
Review Articles
The connection between diabetes mellitus and stroke: a brief review
Junghyun Noh
Cardiovasc Prev Pharmacother. 2025;7(2):55-60.   Published online April 25, 2025
DOI: https://doi.org/10.36011/cpp.2025.7.e7
  • 12,062 View
  • 170 Download
Abstract PDF
Stroke is one of the major macrovascular complications of diabetes and increases morbidity and mortality. Hyperglycemia contributes to a heightened risk of stroke incidence. Moreover, people with diabetes may have poorer post-stroke outcomes and higher risk of stroke recurrence than those without diabetes. Recent cardiovascular outcome trials of some antidiabetic medications have shown beneficial effects on stroke prevention. Prevention and improving outcomes of stroke in patients with diabetes requires proper management of hyperglycemia and additional risk factors. This review is an evidence-based approach to epidemiology of stroke in diabetes, the role of glycemic control, and antidiabetic medications in stroke prevention in patients with diabetes mellitus.
Pharmacological management of diabetes in older adults
Junghyun Noh
Cardiovasc Prev Pharmacother. 2025;7(1):13-20.   Published online January 20, 2025
DOI: https://doi.org/10.36011/cpp.2025.7.e1
  • 16,517 View
  • 203 Download
  • 3 Citations
Abstract PDF
As the global population continues to age, the rising prevalence of diabetes among older adults has become a significant public health concern. Consequently, effective and safe management of diabetes mellitus in this population is an increasingly critical focus in clinical practice. Older patients present considerable variability in functional status, with many experiencing physical disabilities, visual impairments, cognitive decline, or psychological conditions such as depression. Therefore, individualized treatment strategies that consider the presence and progression of geriatric syndromes, comorbidities, and the risk of hypoglycemia are essential for optimizing the pharmacological management of diabetes in older adults.

Citations

Citations to this article as recorded by  
  • Medication Use Patterns, Polypharmacy, and Potentially Inappropriate Medications among Institutionalized Older Adults in East Coast Malaysia: A Cross-sectional Study
    Azlini Ismail, Basma Ezzat Mustafa, Farah Natashah Mohd, Muhd Firdaus Che Musa, Nazih Shaban Mustafa, Khairani Idah Mokhtar, Yunita Dewi Ardini, Omar Abdul Jabbar Abdul Qader
    Journal of Research in Pharmacy Practice.2026;[Epub]     CrossRef
  • Unlocking the dual healing powers of plant-based metallic nanoparticles: managing diabetes and tackling male infertility challenges
    Ayesha Siddiqa, Rahmatullah Qureshi, Ghazala Yasmin, Shaista Rafique, Noor-Ul-Ain Zafar, Chudary Sadam Hussain, Sana ur Rehman, Neelum Naheed
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • SITAGLIPTIN IN TYPE 2 DIABETES MANAGEMENT: A STUDY OF ADD ON THERAPY IN BALI, INDONESIA
    ANAK AGUNG KETUT PURNAMA SARI, PHEBE HENDRA, DITA MARIA VIRGINIA
    Asian Journal of Pharmaceutical and Clinical Research.2025; : 115.     CrossRef
Original Article
Public awareness of cardiovascular disease prevention in Korea
Eunji Kim, Chan-Hee Jung, Eun-Jung Rhee, Junghyun Noh, Jae Hyuk Lee, Hun-Jun Park, Sungha Park, Sang-Hyun Ihm, Won-Young Lee, Hyeon Chang Kim
Cardiovasc Prev Pharmacother. 2022;4(4):149-157.   Published online October 26, 2022
DOI: https://doi.org/10.36011/cpp.2022.4.e20
  • 7,062 View
  • 61 Download
  • 1 Citations
Abstract PDFSupplementary Material
Background
The burden of cardiovascular disease (CVD) is significant in Korea. Ultimately, public knowledge and awareness of CVD risk factors and prevention are essential to reduce its burden. Hence, this study aimed to examine the level of public awareness of CVD risk factors and prevention in Korea in 2022.
Methods
We used data from the Cardiovascular Disease Prevention Awareness Survey conducted by the Korean Society of Cardiovascular Disease Prevention in June 2022. Using a structured web-based questionnaire, 2,000 individuals aged 20 years or more were surveyed on computers or mobile devices. Information on sociodemographic characteristics, the presence of cardiometabolic disease, CVD concerns and self-assessed likelihood, and awareness of CVD prevention were analyzed.
Results
Cancer (44.3%) was the most feared disease, followed by CVD (19.5%). Nevertheless, most respondents stated that they were likely to develop CVD in their lifetime (67.4%). Only 9.2% of respondents were aware of the details of recommendations to prevent CVD, and this level of knowledge was also low among respondents with cardiometabolic diseases (10.7%). Not smoking, being physically active, eating a healthy diet, and reducing alcohol consumption were deemed easy to implement. On the contrary, reducing stress, being physically active, and eating a healthy diet were considered the most difficult recommendations to practice.
Conclusions
Public awareness of CVD risk factors and prevention appeared to be insufficient in Korea. Our research suggests that simple but practical recommendations should be conveyed and promoted to raise public awareness, which is currently inadequate.

Citations

Citations to this article as recorded by  
  • Guidelines for Holter and Wearable Electrocardiogram Monitoring in Arrhythmia Diagnosis and the Role of Medical Technologists
    Do-Hee KIM, Ji-Yeon CHANG
    Korean Journal of Clinical Laboratory Science.2025; 57(2): 215.     CrossRef

CPP : Cardiovascular Prevention and Pharmacotherapy
TOP